| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.66▲ | 10.64▲ | 10.64▲ | 10.37▲ | 11.16▼ |
| MA10 | 10.64▲ | 10.71▼ | 10.70▲ | 10.25▲ | 11.73▼ |
| MA20 | 10.64▲ | 10.37▲ | 10.32▲ | 11.29▼ | 12.05▼ |
| MA50 | 10.21▲ | 10.26▲ | 10.39▲ | 11.88▼ | 7.39▲ |
| MA100 | 10.25▲ | 11.24▼ | 11.56▼ | 11.92▼ | 4.28▲ |
| MA200 | 11.43▼ | 12.05▼ | 11.97▼ | 8.65▲ | 3.16▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.022▼ | 0.018▲ | 0.051▲ | -0.020▼ | -0.576▼ |
| RSI | 55.287▲ | 53.915▲ | 53.392▲ | 44.273▼ | 50.926▲ |
| STOCH | 35.957 | 25.256 | 32.317 | 48.535 | 34.680 |
| WILL %R | -49.074 | -66.860 | -30.504 | -54.545 | -67.410 |
| CCI | 53.070 | 16.648 | 32.699 | -9.115 | -125.532▼ |
|
Tuesday, March 31, 2026 12:06 PM
NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to treat cancer and ...
|
|
Thursday, March 05, 2026 01:05 PM
Data readout for SIM0505/CDH6 ADC Phase 1 dose escalation study and initiation of dose optimization in ovarian cancer are both anticipated in Q2 2026 LNCB74 Phase 1 dose escalation trial update ...
|
|
Friday, January 23, 2026 04:49 AM
(RTTNews) - Next Cure Inc. (NXTC) outlined steady clinical and operational momentum across its two antibody-drug conjugate programs while reporting a preliminary year-end cash position that supports ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 10.31 | 10.72 | 10.31 | 10.72 | 10,781 |
| 01/04/26 | 11.204 | 11.28 | 10.48 | 10.53 | 8,866 |
| 31/03/26 | 10.00 | 10.85 | 9.4101 | 10.68 | 35,853 |
| 30/03/26 | 9.87 | 10.385 | 8.82 | 9.90 | 61,514 |
| 27/03/26 | 10.21 | 10.70 | 9.73 | 10.01 | 21,308 |
| 26/03/26 | 10.41 | 10.945 | 10.01 | 10.13 | 31,535 |
| 25/03/26 | 9.99 | 10.53 | 9.77 | 10.19 | 37,649 |
| 24/03/26 | 10.30 | 10.99 | 9.205 | 9.94 | 62,726 |
| 23/03/26 | 10.13 | 10.795 | 9.8501 | 10.41 | 11,383 |
| 20/03/26 | 9.89 | 10.34 | 9.675 | 9.99 | 23,890 |
|
|
||||
|
|
||||
|
|